You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study

Article metrics

Article menu

Download PDFPDF

Spondyloarthritis
Original article
Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study

 

Online download statistics by month:

Online download statistics by month: October 2018 to September 2024

AbstractFullPdf
Oct 2018929238
Nov 2018596035
Dec 2018514926
Jan 2019353510
Feb 2019232311
Mar 2019484620
Apr 2019242415
May 2019272712
Jun 2019282811
Jul 201922218
Aug 201930289
Sep 2019252613
Oct 2019383414
Nov 201922209
Dec 2019322713
Jan 202027227
Feb 202025247
Mar 202019186
Apr 2020242417
May 202017176
Jun 202019163
Jul 2020242411
Aug 202012124
Sep 2020262312
Oct 2020363618
Nov 202026247
Dec 202018175
Jan 2021262611
Feb 2021241910
Mar 202126199
Apr 2021171513
May 2021212010
Jun 202128278
Jul 202114135
Aug 2021353314
Sep 20211284
Oct 2021262514
Nov 2021262015
Dec 202121195
Jan 202221182
Feb 202249506
Mar 2022262614
Apr 2022546126
May 2022524918
Jun 202238357
Jul 202215152
Aug 202227287
Sep 2022333112
Oct 202241386
Nov 2022161717
Dec 20221095
Jan 2023201612
Feb 202338386
Mar 2023403514
Apr 20231296
May 202311109
Jun 202315137
Jul 2023161710
Aug 202315158
Sep 2023665
Oct 202329294
Nov 202340395
Dec 202374628
Jan 2024776
Feb 202414128
Mar 2024262350
Apr 2024232213
May 2024222210
Jun 202421184
Jul 2024353119
Aug 2024211813
Sep 2024272611
Total19991886815